Agios Unveils Latest Pyrukynd Mitapivat Findings: Promising Long-Term Safety and Hemoglobin Improvement in Non-Transfusion Dependent Patients

Agios Pharmaceuticals Presents Updated PYRUKYND® Data Actively Enrolling Phase 3 ENERGIZE and ENERGIZE-T Studies Agios Pharmaceuticals, Inc. is currently conducting Phase 3 ENERGIZE and ENERGIZE-T studies to evaluate the effectiveness of PYRUKYND® in adults with non-transfusion-dependent and transfusion-dependent α- or β-Thalassemia, respectively. This innovative drug has shown promise in improving outcomes for patients with these…

Read More

Hey Shareholders, Listen Up! You’ve Got a Chance to Take Action with WBTN and Bronstein, Gewirtz & Grossman LLC

Class Action Lawsuit Filed Against WEBTOON Entertainment, Inc. What’s Going On? Well, folks, it looks like WEBTOON Entertainment, Inc. is in hot water. A class action lawsuit has been filed against the company and some of its officers for alleged violations of federal securities laws. Yikes! The lawsuit aims to recover damages for all those…

Read More

Innovative Suprachoroidal Delivery Technology to be Showcased at Upcoming Medical Meetings

Multiple Podium and Poster Presentations on XIPERE® and Gene Therapy Delivery Utilizing SCS Microinjector® ALPHARETTA, Ga., July 07, 2022 (GLOBE NEWSWIRE) – Researchers and industry leaders in the field of ophthalmology gathered at the annual Ophthalmology Innovation Summit (OIS) to discuss the latest advancements in ocular drug delivery. One of the key topics of discussion…

Read More

Breaking Records: Crypto Options Volume Peaks Before Bitcoin ETF Deadline – A Closer Look at BTC and ETH Reactions

The Rise of Crypto Derivatives Market The Impact of Institutional Investors on Crypto Options and Futures A Surge in Trading Volumes The recovery of the overall crypto market this year has spurred a surge in the digital-asset derivatives market as institutional investors seek exposure to the crypto space. According to a recent Bloomberg report, the…

Read More

“Unlocking the Secret to Tax-Friendly Dividends: Claros Mortgage Trust Inc. Reveals 2024 Tax Treatment”

Welcome to the World of Tax Treatment The Latest News from Claros Mortgage Trust, Inc. NEW YORK–(BUSINESS WIRE)–Claros Mortgage Trust, Inc. (NYSE: CMTG) (the “Company” or “CMTG”) today announced the tax treatment of its 2024 common stock dividends. The following table summarizes CMTG’s common stock dividend payments per share for the tax year ended December…

Read More

American Resources Corporation, REElement Technologies, and POSCO International Join Forces to Create a Sustainable Supply Chain for Rare Earth Elements and Magnets

Charmingly eccentric, full of personality, and designed for maximum reader engagement Expanding Opportunities in Rare Earth Element Refining and Recycling The recent Memorandum of Understanding (MOU) signed between ReElement and POSCO marks a significant milestone in the pursuit of sustainable rare earth element production. By leveraging ReElement’s innovative technology for rare-earth magnet recycling and ore…

Read More